The involvement of platelet-derived growth factor receptors and insulin-like growth factor-1 receptors signaling during mineralized nodule formation by human periodontal ligament cells

Journal of Periodontal Research

Volumn 39, Issue 6, 2004, Pages 388-397

  Nemoto, Eiji ^a,b   Shimonishi, Mitsuru ^a   Nitta, Yasutaka ^a   Shimauchi, Hidetoshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Insulin like growth factor; Mineralization; Periodontal ligament cells; Platelet derived growth factor

Indexed keywords

6,7 DIMETHOXY 2 PHENYLQUINOXALINE; 6,7 DIMETHYL 2 PHENYLQUINOXALINE; AG 1024; AG 538; AG 99; ASCORBIC ACID; DEXAMETHASONE; ENZYME INHIBITOR; GLYCEROL 2 PHOSPHATE; LIGAND; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN DERIVATIVE; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CELL; CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; MINERALIZATION; PERIODONTAL LIGAMENT; PERIODONTICS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAINING;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ASCORBIC ACID; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DEXAMETHASONE; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PERIODONTAL LIGAMENT; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOOTH CALCIFICATION;

EID: 8744268282     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00750.x     Document Type: Article

References (54)

1. MacNeil RL, Somerman MJ. Development and regeneration of the periodontium: parallels and contrasts. Periodontol 2000 1999;19:8-20.
2. Nojima N, Kobayashi M, Shionome M, Takahashi N, Suda T, Hasegawa K. Fibroblastic cells derived from bovine periodontal ligaments have the pheno-types of osteoblasts. J Periodont Res 1990;25:179-185.
3. Cho MI, Matsuda N, Lin WL, Moshier A, Ramakrishnan PR. In vitro formation of mineralized nodules by periodontal ligament cells from the rat. Calcif Tissue Int 1992;50:459-467.
4. Arceo N, Sauk JJ, Moehring J, Foster RA, Somerman MJ. Human periodontal cells initiate mineral-like nodules in vitro. J Periodontol 1991;62:499-503.
5. Chien HH, Lin WL, Cho MI. Interleukin-1β-induced release of matrix proteins into culture media causes inhibition of mineralization of nodules formed by periodontal ligament cells in vitro. Calcif Tissue Int 1999;64:402-413.
6. Ramakrishnan PR, Lin WL, Sodek J, Cho MI. Synthesis of noncollagenous extra-cellular matrix proteins during development of mineralized nodules by rat periodontal ligament cells in vitro. Calcif Tissue Int 1995;57:52-59.
7. Lin WL, Chien HH, Cho MI. N-Cadherin expression during periodontal ligament cell differentiation in vitro. J Periodontol 1999;70:1039-1045.
8. Chien HH, Lin WL, Cho MI. Expression of TGF-β isoforms and their receptors during mineralized nodule formation by rat periodontal ligament cells in vitro. J Periodont Res 1999;34:301-309.
9. LaRochelle WJ, Jeffers M, McDonald WF et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 2001;3:517-521.
10. Bergsten E, Uutela M, Li X, Pietras K et al. PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor. Nat Cell Biol 2001;3:512-516.
11. Li X, Ponten A, Aase K et al. PDGF-C is a new pro tease-activated ligand for the PDGF α-receptor. Nat Cell Biol 2000;2:302-309.
12. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-1316.
13. Lasky JA, Coin PG, Lindroos PM, Ostrowski LE, Brody AR, Bonner JC. Chrysotile asbestos stimulates platelet-derived growth factor-AA production by rat lung fibroblasts in vitro: evidence for an autocrine loop. Am J Respir Cell Mol Biol 1995;12:162-170.
14. Rydziel S, Canalis E. Expression and growth factor regulation of platelet-derived growth factor B transcripts in primary osteoblast cell cultures. Endocrinology 1996;137:4115-4119.
15. Nagaoka I, Honma S, Someya A, Iwabuchi K, Yamashita T. Differential expression of the platelet-derived growth factor-A and -B genes during maturation of monocytes to macrophages. Comp Biochem Physiol B 1992;103:349-356.
16. Gilbertson DG, Duff ME, West JW et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor. J Biol Chem 2001;276:27406-27414.
17. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995;16:143-163.
18. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-153.
19. Rutherford RB, TrailSmith MD, Ryan ME, Charette MF. Synergistic effects of dexamethasone on platelet-derived growth factor mitogenesis in vitro. Arch Oral Biol 1992;37:139-145.
20. Ivanovski S, Haase HR, Bartold PM. Isolation and characterization of fibroblasts derived from regenerating human periodontal defects. Arch Oral Biol 2001;46:679-688.
21. Matsuda N, Lin WL, Kumar NM, Cho MI, Genco RJ. Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J Periodontol 1992;63:515-525.
22. Oates TW, Rouse CA, Cochran DL. Mitogenic effects of growth factors on human periodontal ligament cells in vitro. J Periodontol 1993;64:142-148.
23. Giannobile WV, Hernandez RA, Finkelman RD et al. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-1, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodont Res 1996;31:301-312.
24. Lynch SE, Williams RC, Poison AM et al. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 1989;16:545-548.
25. Cochran DL, Wozney JM. Biological mediators for periodontal regeneration. Periodontol 2000 1999;19:40-58.
26. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997;68:1186-1193.
27. Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network, receptor heterodimerization in development and cancer. EMBO J 2000;19:3159-3167.
28. Matsuda N, Morita N, Matsuda K, Watanabe M. Proliferation and differentiation of human osteoblastic cells associated with differential activation of MAP kinases in response to epidermal growth factor, hypoxia, and mechanical stress in vitro. Biochem Biophys Res Commun 1998;249:350-354.
29. Basciani S, Mariani S, Arizzi M et al. Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-α and -β during human testicular development and disease. J Clin Endocrinol Metab 2002;87:2310-2319.
30. Yang Y, Niu J, Guo L. The effects of antisense insulin-like growth factor-I receptor oligonucleotide on human cord blood lymphocytes. J Mol Endocrinol 2002;28:207-212.
31. Naruse I, Ohmori T, Ao Y, et al. Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo. Int J Cancer 2002;98:310-315.
32. Zwerner JP, May WA. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene 2001;20:626-633.
33. Changsirikulchai S, Hudkins KL, Goodpaster TA et al. Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int 2002;62:2043-2054.
34. Chatzistamou I, Serially AV, Varga JL et al. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice. J Clin Endocrinol Metab 2001;86:2144-2152.
35. Shi S, Robey PG, Gronthos S. Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis. Bone 2001;29:532-539.
36. Oates TW, Kose KN, Xie JF, Graves DT, Collins JM, Cochran DL. Receptor binding of PDGF-AA and PDGF-BB, and the modulation of PDGF receptors by TGF-β, in human periodontal ligament cells. J Cell Physiol 1995;162:359-366.
37. Parkar MH, Kuru L, Giouzeli M, Olsen I. Expression of growth-factor receptors in normal and regenerating human periodontal cells. Arch Oral Biol 2001;46:275-284.
38. Paulsson Y, Karlsson C, Heldin CH, Westermark B. Density-dependent inhibitory effect of transforming growth factor-β 1 on human fibroblasts involves the down-regulation of platelet-derived growth factor α-receptors. J Cell Physiol 1993;157:97-103.
39. Matsuda N, Kumar NM, Ramakrishnan PR, Lin WL, Genco RJ, Cho MI. Evidence for up-regulation of epidermal growth-factor receptors on rat periodontal ligament fibroblastic cells associated with stabilization of phenotype in vitro. Arch Oral Biol 1993;38:559-569.
40. Yu X, Hsieh SC, Bao W, Graves DT. Temporal expression of PDGF receptors and PDGF regulatory effects on osteoblastic cells in mineralizing cultures. Am J Physiol 1997;272:C1709-C1716.
41. Kovalenko M, Gazit A, Bohmer A et al. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 1994;54:6106-6114.
42. Parrizas M, Gazit A, Levitzki A, Wertheimer E, LeRoith D. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 1997;138:1427-1433.
43. Blum G, Gazit A, Levitzki A. Substrate competitive inhibitors of IGF-1 receptor kinase. Biochemistry 2000;39:15705-15712.
44. Pai R, Ohta M, Itani RM, Sarfeh IJ, Tarnawski AS. Induction of mitogen-activated protein kinase signal transduction pathway during gastric ulcer healing in rats. Gastroenterology 1998;114:706-713.
45. Frasca F, Pandini G, Scalia P et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 1999;19:3278-3288.
46. Cheng SL, Zhang SF, Mohan S et al. Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone. J Cell Biochem 1998; 71:449-458.
47. Yoshiko Y, Hirao K, Maeda N. Dexamethasone regulates the actions of endogenous insulin-like growth factor-II during myogenic differentiation. Life Sci 1998;63:77-85.
48. Saygin NE, Tokiyasu Y, Giannobile WV, Somerman MJ. Growth factors regulate expression of mineral associated genes in cementoblasts. J Periodontol 2000;71: 1591-1600.
49. Christoffersen J, Landis WJ. A contribution with review to the description of mineralization of bone and other calcified tissues in vivo. Anat Rec 1991;230:435-450.
50. Desbois C, Karsenty G. Osteocalcin cluster: implications for functional studies. J Cell Biochem 1995;57:379-383.
51. Hunter GK, Goldberg HA. Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 1993;90:8562-8565.
52. Veis A. Mineral-matrix interactions in bone and dentin. J Bone Miner Res 1993;8(Suppl 2):S493-S497.
53. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285:1028-1032.
54. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res 2001;89:1104-1110.